Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kenedix Office Investment Corporation | K9R | Nov 27, 2024 | 910.00 | +0.55 |
Kenmare Resources Plc | JEVA | Nov 27, 2024 | 4.20 | +0.96 |
Kennametal Inc. | KM3 | Nov 27, 2024 | 27.20 | 0.00 |
Kennedy-Wilson Holdings Inc. | 13K | Nov 27, 2024 | 10.70 | +0.94 |
Kenon Holdings Ltd. Ordinary Shares | 76N | Nov 27, 2024 | 27.00 | +8.00 |
Kenorland Minerals Ltd. | 3WQ0 | Nov 27, 2024 | 0.75 | +4.17 |
Kentima Holding B | 3K8 | Nov 27, 2024 | 0.16 | -3.09 |
Kenvue | J4D | Nov 27, 2024 | 22.70 | +0.20 |
Keppel Corporation Ltd | KEP1 | Nov 27, 2024 | 4.69 | +0.43 |
KEPPEL REIT UTS | H27 | Nov 27, 2024 | 0.59 | +0.10 |
Kering | PPXB | Nov 27, 2024 | 22.60 | +3.67 |
Kering SA | PPX | Nov 27, 2024 | 225.40 | +2.36 |
Kerlink | 344 | Nov 27, 2024 | 0.51 | +2.63 |
Kernel Holding SA | 0KE | Nov 27, 2024 | 3.21 | +5.41 |
Kerry Group Plc | KRZ | Nov 27, 2024 | 89.60 | -0.33 |
Kerry Group Plc | KRZA | Nov 27, 2024 | 88.00 | +1.15 |
KERRY LOG NET | KYL | Nov 27, 2024 | 0.89 | +7.88 |
KERRY PPT | KR3 | Nov 27, 2024 | 1.81 | 0.00 |
KESKO A | KEK1 | Nov 27, 2024 | 18.78 | +0.43 |
Kesko B | KEK | Nov 27, 2024 | 18.98 | -0.08 |
Kesselrun Resources Ltd | CMG | Nov 27, 2024 | 0.02 | +16.67 |
Keurig Dr Pepper Inc. | DP5 | Nov 27, 2024 | 30.68 | -1.32 |
Kewaunee Scientific | KEW | Nov 27, 2024 | 40.20 | 0.00 |
Kewpie Corporation | QPJ | Nov 27, 2024 | 21.00 | +1.94 |
Key Tronic Corporation | KT1 | Nov 27, 2024 | 5.15 | +1.98 |
KeyCorp | KEY | Nov 27, 2024 | 18.59 | -0.75 |
Keyence Corporation | KEE | Nov 27, 2024 | 398.30 | -0.95 |
Keyera Corp | K2Y | Nov 27, 2024 | 31.02 | +0.71 |
Keymed Biosciences Inc. | 64Z | Nov 27, 2024 | 4.84 | +2.11 |
Keyrus Progiware | 5UP | Nov 27, 2024 | 7.54 | -0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.